DEPDC1B enhances malignant phenotypes of multiple myeloma through upregulating CCNB1 and inhibiting p53 signaling pathway
出版年份 2023 全文链接
标题
DEPDC1B enhances malignant phenotypes of multiple myeloma through upregulating CCNB1 and inhibiting p53 signaling pathway
作者
关键词
-
出版物
TISSUE & CELL
Volume -, Issue -, Pages 102263
出版商
Elsevier BV
发表日期
2023-11-05
DOI
10.1016/j.tice.2023.102263
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Diagnosis and Management of Multiple Myeloma
- (2022) Andrew J. Cowan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Smoldering multiple myeloma current treatment algorithms
- (2022) S. Vincent Rajkumar et al. Blood Cancer Journal
- CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
- (2022) Xi Chen et al. Frontiers in Endocrinology
- Prognostic and predictive biomarker developments in multiple myeloma
- (2021) Craig T. Wallington-Beddoe et al. Journal of Hematology & Oncology
- MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma
- (2021) Peng Xia et al. Cell Death & Disease
- High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer
- (2019) Huishan Zhao et al. Frontiers in Oncology
- Prognostic Value of DEPDC1 Expression in Tumor and Non-tumor Tissue of Patients With Hepatocellular Carcinoma
- (2019) MASATAKA AMISAKI et al. ANTICANCER RESEARCH
- DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma
- (2019) Chao Zhou et al. BIOSCIENCE REPORTS
- Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer
- (2018) Hui Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis
- (2018) Di Qu et al. CANCER SCIENCE
- Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance
- (2018) Bowen Xie et al. CANCER LETTERS
- DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC
- (2018) Lei Zhang et al. CANCER LETTERS
- Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-κB signaling pathway
- (2017) Qingqing Wang et al. OncoTargets and Therapy
- DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling
- (2014) Yi Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The prognostic value of Cyclin B1 in pancreatic cancer
- (2014) Li Zhou et al. MEDICAL ONCOLOGY
- DEP domains: structurally similar but functionally different
- (2014) Sarah V. Consonni et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- cAMP regulates DEP domain-mediated binding of the guanine nucleotide exchange factor Epac1 to phosphatidic acid at the plasma membrane
- (2012) S. V. Consonni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells
- (2010) Y. Harada et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started